Friday, July 10, 2026

biotech · Alzheimer Disease · Major Depressive Disorder · CGTX

Cognition Therapeutics

Cognition Therapeutics is a biotech organization headquartered in Purchase, USA. It trades on NYSE under ticker CGTX. Primary therapeutic focus areas include Alzheimer Disease, Major Depressive Disorder, Primary biliary

2500 Westchester Ave, Purchase, New York 10577, US HQ
2007 Founded
32 Employees
Public company Type
CGTX · NYSE Ticker
Company details
Status
Public
HQ
2500 Westchester Ave, Purchase, New York 10577, US
Founded
2007
Employees
32
Programs
33
Drugs
26
Patents
12
Clinical program

Nitrate enriched beetroot juice

Unknown · other · Aging

Nitrate enriched beetroot juice for Aging is a Unknown program (other) at COGNITION THERAPEUTICS INC with 1 ClinicalTrials.gov record(s).

Internal code IRB-2026-0019

Full intelligence profile for this program is being prepared.

At a glance

Sponsor
COGNITION THERAPEUTICS INC
Phase
Unknown
Modality
other
Indication
Aging
Status
active
Trials
1